The global bronchoscopy market size was calculated at USD 3.25 billion in 2024 and is projected to surpass around USD 6.82 billion by 2034, expanding at a CAGR of 7.7% from 2025 to 2034. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
The global bronchoscopy market size accounted for USD 3.25 billion in 2024 and predicated to increase from USD 3.5 billion in 2025 to approximately USD 6.82 billion by 2034, at a CAGR of 7.7% from 2025 to 2034.
The U.S. bronchoscopy market size was estimated at USD 747.98 million in 2024 and is predicted to be worth around USD 1,702.27 million by 2034, at a CAGR of 7.8% from 2025 to 2034
North American region has dominated this market in the past and it should continue to grow well during the forecast period as it will generate maximum revenue in the market during the forecast period. As the cases of respiratory diseases of the chronic type have increased in this area and the availability of favorable reimbursement policies in various nations of the North American region will drive market growth in the coming years period the reimbursement policies in the United States are extremely favorable. Growing cases of cancer of the lung especially in the nations like Canada and the United States will drive the market growth. As the number of investments made in the infrastructure of the hospitals have increased in recent years the Asia Pacific region will also show significant growth in the coming years. The amount of expenditure made in the healthcare sector has also increased as the disposable income of the population in these regions has increased. A growing geriatric population will also play an instrumental role in the growth of the Asia Pacific region.
Stacked Graph 123165
North America Leading the Bronchoscopy Market with advance Infrastructure and High Disease Prevalence
In the bronchoscopy market, North America has the upper hand because of the greater burden of respiratory disease, such as COPD and lung cancer. In the U.S. in 2024, it's estimated that around 234,580 people will be diagnosed with lung cancer, with approximately 125,070 deaths attributed to the disease, showing the high importance of early diagnostic tools like the bronchoscope. The region also benefits from its large healthcare infrastructure, financial reimbursement, and the presence of major players like Boston Scientific and Ambu A/S. The United States also performs over 1.2 million outpatient processes of bronchoscopy procedures annually.
Rapid Growth Driven by Rising Respiratory Diseases and Medical Advancements
The bronchoscopy market in Asia Pacific is rapidly growing, driven by increasing cases of lung cancer, COPD, and tuberculosis, led by nations with large populations (such as China and India). Major driving factors include increasing rates of air pollution, increasing tobacco ingestion, and an aging population. Healthcare modernization and accessible procedures that are minimally invasive have also improved diagnostic capabilities in the region. Acceptance of new products such as digital video bronchoscopes and single-use devices has increased along with the developing of investment in hospital infrastructure. Governments have begun pushing the way of technology development to improve the diagnosis of illness early in the disease process and reduce costs.
The number of investments made in hospitals has grown largely due to the growing need for bronchoscopy facilities. An increase in the number of respiratory diseases could be due to many reasons some of which are changes in lifestyle and exposure to pollution. Bronchoscopy is known to be a pulmonology procedure that is interventional. It is performed with the help of the Bronchoscope. In recent years the demand for reusable devices has grown significantly which will lead to the growth of the market during the forecast period.
Endoscopic examination is done with the help of this device and it also helps in detecting any issues with the airways. Growing cases of pneumonia, bronchitis, airway stenosis, tumor, lung cancer, and COPD will drive the market growth during the forecast period. This procedure has important therapeutic indications and diagnostic indications. This procedure is an aerosol-generating process. This is seen to be a high-risk procedure. Close contact of the service provider and the patient increases the risk of contamination of various equipment and it also increases the risk of cross-infection.
There are many reasons that will drive the market growth during the forecast period like the growing cases of respiratory diseases. Increasing pollution in most regions across the world will also drive market growth in the coming year. Favorable reimbursement policies will also drive must be there and it will also increase the use or previous devices and products used in the treatment and the diagnosis. Technological advancements will also play a significant role in the growth of this market during the forecast period. A large number of patients suffering from lung cancer and the increasing number of lung cancer in most of regions across the world will be significant factors that will lead to the growth of the market in the coming years.
Many opportunities for the growth of this market will be provided by the emerging markets of various nations across the world. Constant exposure to pollutants and other harmful gases present in the environment will help in the growth of the market during the forecast period. The increase in the geriatric population across the world is yet another reason that will increase the cases of respiratory diseases and drive market growth.
Lung diseases are extremely common among older adults. The life expectancy of the population has reduced drastically due to the increasing cases of pollution. The need for this procedure is extremely important not only for detection but also helps in the restoration of the airway. When patients suffer from the obstruction of the airway the use of this procedure plays a significant role. The number of chronic diseases of the respiratory tract has grown in recent years. Growing cases of lung cancer will also be another factor that will drive the market growth.
| Report Coverage | Details |
| Market Size in 2025 | USD 3.02 Billion |
| Market Size in 2024 | USD 3.25 Billion |
| Market Size by 2034 | USD 6.82 Billion |
| Growth Rate from 2025 to 2034 | CAGR of 7.7% |
| Largest Market | North America |
| Fastest Growing Market | Asia Pacific |
| Base Year | 2024 |
| Forecast Period | 2025 to 2034 |
| Segments Covered | Product, Usability, Application, End User, and Regions |
| Regions Covered | North America, Asia Pacific, Europe, Latin America, Middle East and Africa |
The bronchoscopes segment held the largest share of 42.30% in the 2024 bronchoscopy market. Under bronchoscopes, the manual bronchoscopes, like flexible (non-robotic) and rigid bronchoscopes. A rigid bronchoscope with a solid hollow metal tube for visualizing and accessing the huge airways, and flexible devices like bendable tubes are mostly considered by doctors.
The robotic bronchoscopes prominently enhance the diagnosis of peripheral lung nodules by providing advanced control, reach, and accurate results better than traditional bronchoscopes. The manual EBUS (endobronchial ultrasound) bronchoscopes are a major advancement in bronchoscopy, enabling in-time ultrasound visualization of structures more clearly across the airway walls for staging and treating lung cancer and different mediastinal conditions. The segment has experienced exponential growth due to these advanced product types.
The robotic navigation and smart systems (navigation systems plus robotic-assisted devices driving demand) are expected to grow at a CAGR of 9.10% during the forecast period. The robotic navigation and smart systems have transformed the bronchoscopy market globally. The virtual bronchoscopy systems use software to generate a 3D seamless view of the airways through CT scans.
It disclosed tool options for educational and planning purposes, also for preliminary assessment before invasive fiber-optic bronchoscopy (FB). The electromagnetic navigation system is exponentially growing with its sensor technology to create a virtual 3D map of the patient's airways via a CT scan. It supports guidance to a specialized bronchoscope for peripheral lung lesions. This is a substantial step towards the growth of the bronchoscopy market.
The diagnosis segment held the largest share of 38.70% in the 2024 global bronchoscopy market. The diagnosis of infections, inflammatory diseases is rapidly increasing, with the prevalence of disease and the advancement of the treatment. The bronchoscopy is a major diagnostic tool for lung cancer detection and other conditions. With the use of tissue sampling and airways, the diagnostic role has extended with the recent technological advancement and development, like EBUS and ENB, largely emerging with advanced imaging techniques like optical coherence tomography (OCT) and confocal laser endomicroscopy (CLE).
The navigation-assisted procedures segment is expected to grow at a CAGR of 9.40% during the forecast period. The navigation-assisted procedure uses technology like robotic-assisted bronchoscopy (RAB) and electromagnetic navigation bronchoscopy (ENB) to enhance precision in the guidance of the bronchoscope to peripheral lung lesions, which are hard to navigate with the conventional method. The segment’s technical approach is effectively targeting the most challenging areas and demonstrating significant developmental growth.
The conventional manual bronchoscopy segment peaked with the largest share of 46.80% in the 2024 global bronchoscopy market. The rigid and flexible bronchoscopy precisely defines the conventional manual bronchoscopy with its advanced technology that has lessened the invasive procedure. The integration of technology into devices and processes has largely acquired a huge area of the bronchoscopy market globally. The precision of the treatment has been achieved with the segment's substantial reach.
The robotic-assisted bronchoscopy (RAB) segment is expected to accelerate at a CAGR of 10.80% during the forecast period. The robotic-assisted bronchoscopy has enhanced the diagnosis of peripheral lung lesions by enabling advanced stability and bronchoscopist precision in the lung system. The RAB segment is emerging with the focused development to fill the gap between the safety of traditional bronchoscopy and precision in percutaneous biopsy.
The hospitals segment held the largest share of 58.20% in the 2024 global bronchoscopy market. The hospitals segment is evolving with the demand for accuracy in treatment and the growing conditions of the lungs. The hospitals become the first source of diagnosis for lung infections. The internal development and access of the hospitals have paved the way for new technological access to sharpen the treatment and rely on the same. The technological advancements and techniques in hospitals like RAB, OCT, and CLE are impressive and trustworthy to patients and healthcare providers.
The ambulatory surgical centers (ASCs) segment is expected to grow at a CAGR of 8.60% during the forecast period. The ASCs enable an outpatient setting for therapeutic and diagnostic bronchoscopies for faster recovery and to diminish healthcare costs. It's affordable than hospitals. The ASCs have emerged with advanced imaging, such as ENB and EBUS, also with specific tools that have contributed mostly to the growth of this segment.
Segments Covered in the Report
By Product Type
By Use Case / Clinical Application
By Technology / Modality
By End User
By Geography
For inquiries regarding discounts, bulk purchases, or customization requests, please contact us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Get a Sample
Schedule a Meeting
Get a Sample
Table Of Content